226 related articles for article (PubMed ID: 37070539)
1. Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIV.
Griffin DWJ; Pai Mangalore R; Hoy JF; McMahon JH
AIDS; 2023 Jul; 37(9):1345-1360. PubMed ID: 37070539
[TBL] [Abstract][Full Text] [Related]
2. High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2.
Pourcher V; Belin L; Soulie C; Rosenzwajg M; Marot S; Lacombe K; Valin N; Pialoux G; Calin R; Palacios C; Malet I; Zafilaza K; Tubiana R; Valantin MA; Klatzmann D; Calvez V; Simon-Tillaux N; Marcelin AG
AIDS; 2022 Sep; 36(11):1545-1552. PubMed ID: 35730380
[TBL] [Abstract][Full Text] [Related]
3. Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
Hassold N; Brichler S; Ouedraogo E; Leclerc D; Carroue S; Gater Y; Alloui C; Carbonnelle E; Bouchaud O; Mechai F; Cordel H; Delagreverie H
AIDS; 2022 Mar; 36(4):F1-F5. PubMed ID: 35013085
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus.
Casado-Fernández G; Cantón J; Nasarre L; Ramos-Martín F; Manzanares M; Sánchez-Menéndez C; Fuertes D; Mateos E; Murciano-Antón MA; Pérez-Olmeda M; Cervero M; Torres M; Rodríguez-Rosado R; Coiras M
Front Immunol; 2024; 15():1362621. PubMed ID: 38812512
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
Hensley KS; Jongkees MJ; Geers D; GeurtsvanKessel CH; Mueller YM; Dalm VASH; Papageorgiou G; Steggink H; Gorska A; Bogers S; den Hollander JG; Bierman WFW; Gelinck LBS; Schippers EF; Ammerlaan HSM; van der Valk M; van Vonderen MGA; Delsing CE; Gisolf EH; Bruns AHW; Lauw FN; Berrevoets MAH; Sigaloff KCE; Soetekouw R; Branger J; de Mast Q; Lammers AJJ; Lowe SH; de Vries RD; Katsikis PD; Rijnders BJA; Brinkman K; Roukens AHE; Rokx C
PLoS Med; 2022 Oct; 19(10):e1003979. PubMed ID: 36301821
[TBL] [Abstract][Full Text] [Related]
6. Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1.
Chammartin F; Griessbach A; Kusejko K; Audigé A; Epp S; Stoeckle MP; Eichenberger AL; Amstutz A; Schoenenberger CM; Hasse B; Braun DL; Rauch A; Trkola A; Briel M; Bucher HC; Günthard HF; Speich B; Abela IA;
AIDS; 2024 Feb; 38(2):217-222. PubMed ID: 37830908
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of inactivated SARS-CoV-2 vaccines in people living with HIV: A longitudinal cohort study.
Li J; Nie L; Guo C; Deng Y; Guo Q; Pang C; Xin R; Li J; Lu H; Huang C
J Med Virol; 2023 Dec; 95(12):e29334. PubMed ID: 38140842
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
[TBL] [Abstract][Full Text] [Related]
9. Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution.
Benet S; Blanch-Lombarte O; Ainsua-Enrich E; Pedreño-Lopez N; Muñoz-Basagoiti J; Raïch-Regué D; Perez-Zsolt D; Peña R; Jiménez E; de la Concepción MLR; Ávila C; Cedeño S; Escribà T; Romero-Martín L; Alarcón-Soto Y; Rodriguez-Lozano GF; Miranda C; González S; Bailón L; Blanco J; Massanella M; Brander C; Clotet B; Paredes R; Esteve M; Izquierdo-Useros N; Carrillo J; Prado JG; Moltó J; Mothe B
J Infect Dis; 2022 Nov; 226(11):1913-1923. PubMed ID: 36200261
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study.
Netto LC; Ibrahim KY; Picone CM; Alves APPS; Aniceto EV; Santiago MR; Parmejani PSS; Aikawa NE; Medeiros-Ribeiro AC; Pasoto SG; Yuki EFN; Saad CGS; Pedrosa T; Lara AN; Ceneviva C; Bonfa E; Kallas EG; Avelino-Silva VI
Lancet HIV; 2022 May; 9(5):e323-e331. PubMed ID: 35338835
[TBL] [Abstract][Full Text] [Related]
11. Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada.
Costiniuk CT; Singer J; Lee T; Galipeau Y; McCluskie PS; Arnold C; Langlois MA; Needham J; Jenabian MA; Burchell AN; Samji H; Chambers C; Walmsley S; Ostrowski M; Kovacs C; Tan DHS; Harris M; Hull M; Brumme ZL; Lapointe HR; Brockman MA; Margolese S; Mandarino E; Samarani S; Vulesevic B; Lebouché B; Angel JB; Routy JP; Cooper CL; Anis AH;
AIDS; 2023 Oct; 37(12):F25-F35. PubMed ID: 37534695
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV.
Motta E; Camacho LAB; Cunha M; de Filippis AMB; Lima SMB; Costa M; Pedro L; Cardoso SW; Cortes FH; Giacoia-Gripp CBW; Morata M; Nazer S; Moreira RI; de Oliveira Souza MC; Mendes YS; Souza Azevedo A; Dos Santos Alvez N; Grinsztejn B; Coelho LE
AIDS; 2023 Dec; 37(15):2319-2329. PubMed ID: 37650759
[TBL] [Abstract][Full Text] [Related]
13. Surrogate neutralization responses following severe acute respiratory syndrome coronavirus 2 vaccination in people with HIV: comparison between inactivated and mRNA vaccine.
Wong NS; Wong BCK; Chan JMC; Wong KH; Tsang OTY; Mok CKP; Hui DSC; Lee SS; Chan DPC
AIDS; 2022 Jul; 36(9):1255-1264. PubMed ID: 35466962
[TBL] [Abstract][Full Text] [Related]
14. The effect of HIV on COVID-19 vaccine responses.
Levy I; Rahav G
Curr Opin HIV AIDS; 2023 May; 18(3):135-141. PubMed ID: 36943427
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
[TBL] [Abstract][Full Text] [Related]
16. Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study.
Yendewa GA; Perez JA; Patil N; McComsey GA
Front Immunol; 2024; 15():1297195. PubMed ID: 38318191
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIV.
Vergori A; Cozzi-Lepri A; Tavelli A; Mazzotta V; Azzini AM; Gagliardini R; Mastrorosa I; Latini A; Pellicanò G; Taramasso L; Ceccherini-Silberstein F; Giannella M; Tacconelli E; Marchetti G; Monforte AD; Antinori A;
Int J Infect Dis; 2024 Jul; 144():107065. PubMed ID: 38643867
[TBL] [Abstract][Full Text] [Related]
18. Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH).
Tuan JJ; Zapata H; Barakat L; Andrews L; Behnegar A; Kim YW; Kayani J; Mutic S; Ryall L; Turcotte B; Critch-Gilfillan T; Zhao M; Salahuddin S; Gupta S; Sutton R; Friedland G; Emu B; Ogbuagu O
BMC Infect Dis; 2022 Sep; 22(1):744. PubMed ID: 36131232
[TBL] [Abstract][Full Text] [Related]
19. The immune response to SARS-CoV-2 in people with HIV.
Höft MA; Burgers WA; Riou C
Cell Mol Immunol; 2024 Feb; 21(2):184-196. PubMed ID: 37821620
[TBL] [Abstract][Full Text] [Related]
20. Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy.
Lapointe HR; Mwimanzi F; Cheung PK; Sang Y; Yaseen F; Speckmaier S; Barad E; Moran-Garcia N; Datwani S; Duncan MC; Kalikawe R; Ennis S; Young L; Ganase B; Omondi FH; Umviligihozo G; Dong W; Toy J; Sereda P; Burns L; Costiniuk CT; Cooper C; Anis AH; Leung V; Holmes D; DeMarco ML; Simons J; Hedgcock M; Prystajecky N; Lowe CF; Romney MG; Barrios R; Guillemi S; Brumme CJ; Montaner JSG; Hull M; Harris M; Niikura M; Brockman MA; Brumme ZL
AIDS; 2023 Apr; 37(5):709-721. PubMed ID: 36545783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
